Objective To study the Batroxobin and Ginkgo leaf Extract and Dipyridamole in the treatment of cerebral infarction efficacy and safety. Methods 88 cases were our of cerebral infarction were randomly divided into control group and treatment group 44 cases each. The comparison group use the Ginkgo leaf Extract and Dipyridamole treatment, the treatment group use the Batroxobin and Ginkgo leaf Extract and Dipyridamole treatment, observation before treatment and after treatment 7, 14, 21 days of the U.S. national institutes of nerve function defect score(NIHSS) scores and daily life ability score(Barthel index, BI) as well as the security situation. Results The two groups before treatment NIHSS score, BI scores are no statistical difference(P >0.05), the seventh day after treatment, day 14, 21 days between the two groups have statistical difference(P <0.05); Two groups were not significantly bleeding occurred. Conclusion The Batroxobin and Ginkgo leaf Extract and Dipyridamole treatment of patients with acute cerebral infarction curative effect is better than the single drug treatment, and good safety.
Cerebral infarctionBatroxobinGinkgo leaf Extract and Dipyridamole
NETL
NSTL
万方数据
维普
